Literature DB >> 21826668

Reduced expression of MUTYH with suppressive activity against mutations caused by 8-hydroxyguanine is a novel predictor of a poor prognosis in human gastric cancer.

Kazuya Shinmura1, Masanori Goto, Masaya Suzuki, Hong Tao, Hidetaka Yamada, Hisaki Igarashi, Shun Matsuura, Matsuyoshi Maeda, Hiroyuki Konno, Tomonari Matsuda, Haruhiko Sugimura.   

Abstract

The MUTYH gene encodes a DNA glycosylase that can initiate the excision repair of adenine mispaired with 8-hydroxyguanine (8OHG) and is responsible for a susceptibility to multiple colorectal adenomas and carcinomas. To determine whether the MUTYH gene is involved in gastric carcinogenesis, we first examined the expression level of MUTYH in gastric cancer. The reduced expression of MUTYH mRNA transcript was detected in both gastric cancer cell lines and primary gastric cancers using qRT-PCR analysis. Immunohistochemical analysis also showed a significant reduction in MUTYH protein expression in gastric cancer, compared with non-cancerous gastric epithelium (immunohistochemical score, 175.5 ± 43.0 versus 281.5 ± 24.8; p < 0.0001). Among the gastric cancers, the MUTYH expression level was significantly associated with the histopathology (p < 0.0001) and the pT stage (p < 0.001). The outcome of patients with gastric cancer exhibiting low MUTYH expression was significantly worse than the outcome of patients with gastric cancer exhibiting high MUTYH expression (p = 0.0007, log-rank test) and a multivariate analysis revealed that reduced MUTYH expression was an independent predictor of a poor survival outcome among the gastric cancer patients (hazard ratio, 1.865; 95% confidence interval, 1.028-3.529; p = 0.0401). We next compared the functional effects of MUTYH on gastric cancer cells, based on their MUTYH expression levels. MUTYH-over-expressing stable clones of the gastric cancer cell line AGS showed: (a) higher DNA cleavage activity towards adenine:8OHG mispair-containing substrates; (b) higher suppressive activity against mutations caused by 8OHG in a supF forward mutation assay; and (c) higher suppressive activity for cellular proliferation than empty vector-transfected AGS clones. These results suggested that MUTYH is a suppressor of mutations caused by 8OHG in gastric cells and that its reduced expression is associated with a poor prognosis in gastric cancer.
Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21826668     DOI: 10.1002/path.2953

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  19 in total

1.  PLK4 overexpression and its effect on centrosome regulation and chromosome stability in human gastric cancer.

Authors:  Kazuya Shinmura; Nobuya Kurabe; Masanori Goto; Hidetaka Yamada; Hiroko Natsume; Hiroyuki Konno; Haruhiko Sugimura
Journal:  Mol Biol Rep       Date:  2014-07-01       Impact factor: 2.316

2.  RSPO fusion transcripts in colorectal cancer in Japanese population.

Authors:  Kazuya Shinmura; Tomoaki Kahyo; Hisami Kato; Hisaki Igarashi; Shun Matsuura; Satoki Nakamura; Kiyotaka Kurachi; Toshio Nakamura; Hiroshi Ogawa; Kazuhito Funai; Masayuki Tanahashi; Hiroshi Niwa; Haruhiko Sugimura
Journal:  Mol Biol Rep       Date:  2014-05-22       Impact factor: 2.316

3.  Genetic Investigation of Polymorphic OGG1 and MUTYH Genes Towards Increased Susceptibility in Lung Adenocarcinoma and its Impact on Overall Survival of Lung Cancer Patients Treated with Platinum Based Chemotherapy.

Authors:  Amrita Singh; Navneet Singh; Digambar Behera; Siddharth Sharma
Journal:  Pathol Oncol Res       Date:  2017-12-05       Impact factor: 3.201

4.  Regulation of human MutYH DNA glycosylase by the E3 ubiquitin ligase mule.

Authors:  Julia Dorn; Elena Ferrari; Ralph Imhof; Nathalie Ziegler; Ulrich Hübscher
Journal:  J Biol Chem       Date:  2014-01-17       Impact factor: 5.157

5.  Mammalian MutY homolog (MYH or MUTYH) protects cells from oxidative DNA damage.

Authors:  Bor-Jang Hwang; Gouli Shi; A-Lien Lu
Journal:  DNA Repair (Amst)       Date:  2013-12-04

6.  CD44-SLC1A2 fusion transcripts in primary colorectal cancer.

Authors:  Kazuya Shinmura; Hisami Kato; Hisaki Igarashi; Yusuke Inoue; Satoki Nakamura; Chunping Du; Kiyotaka Kurachi; Toshio Nakamura; Hiroshi Ogawa; Masayuki Tanahashi; Hiroshi Niwa; Haruhiko Sugimura
Journal:  Pathol Oncol Res       Date:  2015-01-10       Impact factor: 3.201

7.  Impaired suppressive activities of human MUTYH variant proteins against oxidative mutagenesis.

Authors:  Kazuya Shinmura; Masanori Goto; Hong Tao; Shun Matsuura; Tomonari Matsuda; Haruhiko Sugimura
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 8.  MUTYH-associated colorectal cancer and adenomatous polyposis.

Authors:  Satoru Yamaguchi; Hideo Ogata; Daisuke Katsumata; Masanobu Nakajima; Takaaki Fujii; Soichi Tsutsumi; Takayuki Asao; Kinro Sasaki; Hiroyuki Kuwano; Hiroyuki Kato
Journal:  Surg Today       Date:  2013-04-19       Impact factor: 2.549

9.  Cancer-associated variants and a common polymorphism of MUTYH exhibit reduced repair of oxidative DNA damage using a GFP-based assay in mammalian cells.

Authors:  Alan G Raetz; Yali Xie; Sucharita Kundu; Megan K Brinkmeyer; Cindy Chang; Sheila S David
Journal:  Carcinogenesis       Date:  2012-08-26       Impact factor: 4.944

10.  MUTYH-associated polyposis (MAP), the syndrome implicating base excision repair in inherited predisposition to colorectal tumors.

Authors:  Tiziana Venesio; Antonella Balsamo; Vito G D'Agostino; Guglielmina N Ranzani
Journal:  Front Oncol       Date:  2012-08-02       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.